基托桑基纳米颗粒提供的抗病毒可以中和SARS-CoV-2和HCoV-OC43

Avinash Mali1, Gianluigi Franci2, Carla Zannella1

  • 1Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.

Pharmaceutics
|June 28, 2023
PubMed
概括

通过 Hyaluronic 酸/Chitosan 和 Dextran/Chitosan 纳米颗粒传递的新型抗病毒显示出对 SARS-CoV-2 等冠状病毒进行鼻腔治疗的潜力.